Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHB1700019	伏拉瑞韦	furaprevir	Active ingredient	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view
CXHB1700020	伏拉瑞韦胶囊	furaprevir	Capsule	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view
CXHB1700021	磷酸依米他韦	emitasvir phosphate	Active ingredient	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view
CXHB1700022	磷酸依米他韦胶囊	emitasvir phosphate	Capsule	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view
CXHB1700023	磷酸依米他韦胶囊	emitasvir phosphate	Capsule	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view
CXHB1700024	磷酸依米他韦胶囊	emitasvir phosphate	Capsule	Chemical Drugs	Supplementary Application	2017-04-24	东莞东阳光太景医药研发有限责任公司	Dongguan East Sunshine Taijing Pharmaceutical R & D Co Ltd	Certificate Issued	2017-08-29	view